Surgical Science Sweden AB (SUS) - Total Liabilities

Latest as of September 2025: Skr403.58 Million SEK ≈ $43.43 Million USD

Based on the latest financial reports, Surgical Science Sweden AB (SUS) has total liabilities worth Skr403.58 Million SEK (≈ $43.43 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Surgical Science Sweden AB cash conversion from operations to assess how effectively this company generates cash.

Surgical Science Sweden AB - Total Liabilities Trend (2014–2024)

This chart illustrates how Surgical Science Sweden AB's total liabilities have evolved over time, based on quarterly financial data. Check asset resilience ratio of Surgical Science Sweden AB to evaluate the company's liquid asset resilience ratio.

Surgical Science Sweden AB Competitors by Total Liabilities

The table below lists competitors of Surgical Science Sweden AB ranked by their total liabilities.

Company Country Total Liabilities
Tianjin Capital Environmental Protection Group Company Limited
F:TIA
Germany €14.41 Billion
M-tron Industries, Inc.
NYSE MKT:MPTI
USA $5.22 Million
McKinley Acquisition Corporation Class A Ordinary Shares
NASDAQ:MKLY
USA $4.66 Million
Spurcorp
JSE:SUR
South Africa ZAC608.93 Million
Profile Systems & Software SA
AT:PROF
Greece €36.07 Million
Bougainville Copper Ltd
AU:BOC
Australia AU$11.48 Million
Stereotaxis Inc
NYSE MKT:STXS
USA $34.05 Million

Liability Composition Analysis (2014–2024)

This chart breaks down Surgical Science Sweden AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Surgical Science Sweden AB (SUS) total market value.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 4.18 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.09 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.09 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Surgical Science Sweden AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Surgical Science Sweden AB (2014–2024)

The table below shows the annual total liabilities of Surgical Science Sweden AB from 2014 to 2024.

Year Total Liabilities Change
2024-12-31 Skr651.03 Million
≈ $70.06 Million
+82.13%
2023-12-31 Skr357.46 Million
≈ $38.47 Million
-13.47%
2022-12-31 Skr413.11 Million
≈ $44.46 Million
+5.10%
2021-12-31 Skr393.06 Million
≈ $42.30 Million
+769.14%
2020-12-31 Skr45.22 Million
≈ $4.87 Million
-17.08%
2019-12-31 Skr54.54 Million
≈ $5.87 Million
+168.97%
2018-12-31 Skr20.28 Million
≈ $2.18 Million
+51.32%
2017-12-31 Skr13.40 Million
≈ $1.44 Million
-67.56%
2016-12-31 Skr41.30 Million
≈ $4.44 Million
+17.66%
2015-12-31 Skr35.10 Million
≈ $3.78 Million
+200.86%
2014-12-31 Skr11.67 Million
≈ $1.26 Million
--

About Surgical Science Sweden AB

ST:SUS Sweden Health Information Services
Market Cap
$180.22 Million
Skr1.67 Billion SEK
Market Cap Rank
#16931 Global
#281 in Sweden
Share Price
Skr32.82
Change (1 day)
+0.92%
52-Week Range
Skr23.92 - Skr159.20
All Time High
Skr324.75
About

Surgical Science Sweden AB (publ) develops and markets virtual reality simulators for evidence-based medical training in Europe, North and South America, Asia, and internationally. The company offers Angio Mentor simulator for endovascular training; BRONCH Express, a portable version of BRONCH mentor simulator; ARTHRO Mentor for arthroscopic surgery skills acquisition; BRONCH Mentor, a simulator … Read more